Companies · Other Health Care

Equiscript Holdings, Inc.

NORTH CHARLESTON · Other Health Care

Diligence memoA one-page analyst read on Equiscript Holdings, Inc. — recommendation, valuation, rhythm, risks.
$2.1M
Total raised · real
2
Rounds
2.0×
Latest step-up
Top 53%
Sector rank · raised
Seed
Latest stage · inferred · Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Equiscript Holdings, Inc. looks under-valued against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.47× the median modeled value of Seed Other Health Care companies in 2022–2024 (244 peers) — value vs value, same stage and era.
At-risk
  • Last raise 2.6 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Equiscript Holdings, Inc. behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
4.3 yr record
Peak capital year was 2022 with $1.6M across 2 filings.
Market position
ahead of 48% of Other Health Care peers
Capital scale is ahead of 48% of Other Health Care peers; modeled value is above 23% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2022: $1.6M across 2 filings.
  • Largest single filing was $1.1M on 2022-03-01.
  • Filing rows sum to $2.6M, while canonical raised total is $2.1M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Equiscript Holdings, Inc. is one of 5376 Other Health Care companies tracked from NORTH CHARLESTON. By capital raised it ranks mid-pack (ahead of 48% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
4
Investors (latest)
2019
Year incorporated
2023-12-12
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$5.0M$10M$15M$20MSeed · 2022-03-01 Raised $1.1M (real) Modeled valuation $13M (est)$1.1M$13MSeed2022Pre-Seed · 2022-03-01 Raised $500K (real) Modeled valuation $6.7M (est)$500K$6.7MPre-Seed2022Seed · 2023-12-12 Raised $1.0M (real) Modeled valuation $5.6M (est)$1.0M$5.6MSeed2023+$500K+$1.0MCumulative $2.6M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.1M · 2022
Bridge · Seed-stage$500K · 2022smaller follow-on
Seed extension$1.0M · 2023

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$5.6M
Base estimate est.
$846K
Conservative case
$17.4M
Upside case
$5.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $13.3M · 2022-03-012022Pre-Seed · modeled $6.7M · 2022-03-01Seed · modeled $5.6M · 2023-12-122023
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
2.5 yr
Elapsed time used
2.5 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
11 mo
Avg between rounds
$1.2M/yr
Capital velocity
4.3 yr
On record since
2022
First round
3
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.9× of median
This company$2.1M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.6× of median
This company$1.0M
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 0.3× of median
This company$5.6M
Sector median$22.1M

Raised more than 48% of sector peers (real $). Modeled value above 23% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #199 of 244.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0M$10.0MCapital raised (log)Elmntri LLC · Seed Raised $4.0M · modeled $46.1M (est)Atreo, Inc. · Seed Raised $3.8M · modeled $42.1M (est)descendantsDNA, Inc. · Seed Raised $3.4M · modeled $40.8M (est)Westover Project Investor LLC · Seed Raised $4.0M · modeled $39.9M (est)Dentulu Inc · Seed Raised $6.4M · modeled $37.6M (est)Emmacare.com LLC · Seed Raised $3.0M · modeled $37.2M (est)IR-Med, Inc. · Seed Raised $5.4M · modeled $36.9M (est)SDH Parent 2 LLC · Seed Raised $3.0M · modeled $36.7M (est)TecTraum, Inc. · Seed Raised $7.8M · modeled $36.6M (est)DBN BCS II Investments, LLC · Seed Raised $3.0M · modeled $34.0M (est)USRC Baldwin Hills, LLC · Seed Raised $2.8M · modeled $33.9M (est)Flex Operating Room, Inc. · Seed Raised $6.2M · modeled $31.8M (est)Equiscript Holdings, Inc. (this company) Raised $2.1M · modeled $5.6M (est)Equiscript Holdings, Inc.
CompanyStageRaised · realValue · estvs peer med.
Elmntri LLCSeed$4.0M$46.1M3.83×
Atreo, Inc.Seed$3.8M$42.1M3.50×
descendantsDNA, Inc.Seed$3.4M$40.8M3.40×
Westover Project Investor LLCSeed$4.0M$39.9M3.33×
Dentulu IncSeed$6.4M$37.6M3.13×
Emmacare.com LLCSeed$3.0M$37.2M3.10×
IR-Med, Inc.Seed$5.4M$36.9M3.08×
SDH Parent 2 LLCSeed$3.0M$36.7M3.05×
TecTraum, Inc.Seed$7.8M$36.6M3.05×
DBN BCS II Investments, LLCSeed$3.0M$34.0M2.83×
USRC Baldwin Hills, LLCSeed$2.8M$33.9M2.82×
Flex Operating Room, Inc.Seed$6.2M$31.8M2.65×
Equiscript Holdings, Inc. this companySeed$2.1M$5.6M0.47×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.1M2022-03-01$5.5M$13.3M90%
Pre-Seed$500K2022-03-01$2.8M$6.7M90%
Seed$1.0M2023-12-12$5.0M$5.6M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.1M2022-03-01
    • First recorded raise — entered as Seed.
    • 4 investors on this round.
  2. Pre-Seed$500K2022-03-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.2× smaller than the prior — bridge or down round.
    • 4 investors on this round.
  3. Seed$1.0M2023-12-12
    • Raised again after 21 mo — slower than the ~14 mo sector norm.
    • Round 2.0× larger than the prior — scaling up.
    • 4 investors on this round.
Intelligence
2024 ~Q4
Modeled next raise · ~11mo cadence
$2.0M
Modeled next size est.range $1.3M$3.2M
2.0×
Last step-up
$1.2M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
James Bradley5 other2022-03
Rebecca M. Shanahan1 other2022-03
Rebecca Shanahan1 other2023-12
Carl Hoburg2023-12
Charles B. West, III2022-03
Ed B. Nenon2022-03
Michael Burkhold, Jr.2022-03
Ron B. Geguzys2022-03
Steven M. Kerr2022-03
Registry & provenance

Equiscript Holdings, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1916343
SEC CIK
2019
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
SS Radiology Holdco, LLCOther Health CareSeed$2.2M$6.5Msame sector · same stage
Tomball Surgicenter, LLCOther Health CareSeed$2.2M$6.3Msame sector · same stage
SiteLabs Inc.Other Health CareSeed$2.0M$5.5Msame sector · same stage
Harmonus IncOther Health CareSeed$2.2M$5.0Msame sector · same stage
Imagen Vogel Support Services, LLCOther Health CareSeed$2.2M$5.3Msame sector · same stage
CloSys CorpOther Health CareSeed$2.3M$6.5Msame sector · same stage
Imagen Prestige Dentistry Support Services, LLCOther Health CareSeed$2.4M$5.8Msame sector · same stage
PS Center, LLCOther Health CareSeed$2.5M$4.6Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Aquity Holdings, Inc.Other Health CareSeries B$797.6M85%
Equip Health, Inc.HealthtechSeries C$343.2M84%
SmartScripts Holdings LLCOther Health CareSeries B$262.3M83%
Ebh Holding Company, Inc.Other Health CareSeries B$871.1M83%
Inquisithealth, Inc.Other Health CareSeed$13.7M83%
EO Enterprises, LLCOther Health CarePre-Seed$623K83%
Equum Management Holdings, LLCOther Health CareSeries B$478.8M83%
Eisana CorpOther Health CareSeed$22.4M82%
Frequently asked
How much funding has Equiscript Holdings, Inc. raised?
Equiscript Holdings, Inc. has raised approximately $2.1M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Equiscript Holdings, Inc.'s estimated valuation?
Provath's modeled valuation for Equiscript Holdings, Inc. is approximately $5.6M (modeled range $846K–$17.4M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Equiscript Holdings, Inc. at?
Equiscript Holdings, Inc.'s latest modeled financing stage is Seed. Its most recent recorded round closed around Tue Dec 12.
What does Equiscript Holdings, Inc. do and where is it based?
Equiscript Holdings, Inc. operates in the Other Health Care sector, based in NORTH CHARLESTON.
Explore related

See where Equiscript Holdings, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Equiscript Holdings, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.